Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes (Q73814889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Silvia Gregori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Trembleau S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gately MK

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Adorini L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

2330-2339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Lymphokine production by human T cells in disease states

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

T helper cell subsets in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Mechanisms influencing the immunodominance of T cell determinants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Expression of PTP35, the murine homologue of the protein tyrosine phosphatase-related sequence IA-2, is regulated during cell growth and stimulated by mitogens in 3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

The role of IL-12 in the induction of organ-specific autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Effect of adjuvant therapy on development of diabetes in mouse and man.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270930

7 January 2021

Identifiers

DOI

10.1002/EJI.1830270930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341777%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference